Antifungal Therapy Could Benefit Nearly 5 Million Asthmatics Worldwide

MNT "An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University. "